XML 66 R52.htm IDEA: XBRL DOCUMENT v3.22.0.1
Financial Information of Registrant (Parent Company Only) (Tables)
12 Months Ended
Jan. 02, 2022
Condensed Financial Information Of Parent Company Only Disclosure [Abstract]  
Schedule of Condensed Statement of Comprehensive Income

Statements of operations and comprehensive loss

(In millions)

 

 

 

Fiscal Year Ended

 

 

 

January 2, 2022

 

 

January 3, 2021

 

 

December 29, 2019

 

Selling, marketing and administrative expenses

 

$

3.5

 

 

$

 

 

$

 

Equity in loss of subsidiaries

 

 

(50.8

)

 

 

(211.9

)

 

 

(156.9

)

Net loss

 

 

(54.3

)

 

 

(211.9

)

 

 

(156.9

)

Equity in other comprehensive income (loss) of subsidiaries

 

 

24.7

 

 

 

4.2

 

 

 

(19.7

)

Total comprehensive loss

 

$

(29.6

)

 

$

(207.7

)

 

$

(176.6

)

Schedule of Condensed Balance Sheet

Balance sheets

(In millions, except share and per share data)

 

 

 

January 2, 2022

 

 

January 3, 2021

 

Assets

 

 

 

 

 

 

Current assets:

 

 

 

 

 

 

Cash and cash equivalents

 

$

17.0

 

 

$

1.8

 

Receivables from subsidiaries

 

 

 

 

 

0.2

 

Investments in subsidiaries

 

 

400.9

 

 

 

 

Loans receivable from subsidiaries

 

 

 

 

 

3.2

 

Total assets

 

$

417.9

 

 

$

5.2

 

Liabilities and Shareholders’ Equity (Deficit)

 

 

 

 

 

 

Payables to subsidiaries

 

$

6.9

 

 

$

0.8

 

Accrued expenses

 

 

0.5

 

 

 

 

Investments in subsidiaries

 

 

 

 

 

1,015.2

 

Total liabilities

 

 

7.4

 

 

 

1,016.0

 

Preferred Redeemable shares, $1.39 nominal value per share, 50,000 and no shares
   issued and outstanding as of January 2, 2022 and January 3, 2021

 

 

0.1

 

 

 

 

Ordinary shares, $0.00001 par value, 1,000,000,000 shares authorized, 237,203,879 
   and
147,295,511 shares issued and outstanding as of January 2, 2022 and
   January 3, 2021, respectively

 

 

 

 

 

 

Additional paid-in capital

 

 

2,425.9

 

 

 

975.1

 

Accumulated deficit

 

 

(1,971.8

)

 

 

(1,917.5

)

Accumulated other comprehensive loss

 

 

(43.7

)

 

 

(68.4

)

Total shareholders’ equity (deficit)

 

 

410.5

 

 

 

(1,010.8

)

Total liabilities and shareholders’ equity (deficit)

 

$

417.9

 

 

$

5.2

 

Schedule of Condensed Cash Flow Statement

Statements of cash flows

(In millions)

 

 

 

Fiscal Year Ended

 

 

 

January 2, 2022

 

 

January 3, 2021

 

 

December 29, 2019

 

Cash Flows from Operating Activities:

 

 

 

 

 

 

 

 

 

Net loss

 

$

(54.3

)

 

$

(211.9

)

 

$

(156.9

)

Adjustments to reconcile net loss to cash used in operating activities:

 

 

 

 

 

 

 

 

 

Equity loss in subsidiaries

 

 

50.8

 

 

 

211.9

 

 

 

156.9

 

Changes in operating assets and liabilities

 

 

4.5

 

 

 

 

 

 

 

Cash provided by operating activities

 

 

1.0

 

 

 

 

 

 

 

Cash Flows from Investing Activities:

 

 

 

 

 

 

 

 

 

Increase in investment in subsidiaries

 

 

(1,416.1

)

 

 

 

 

 

 

Net increase in intercompany loans

 

 

 

 

 

 

 

 

(3.3

)

Cash used in investing activities

 

 

(1,416.1

)

 

 

 

 

 

(3.3

)

Cash Flows from Financing Activities:

 

 

 

 

 

 

 

 

 

Proceeds from initial public offering

 

 

1,426.4

 

 

 

 

 

 

 

Payment of initial public offering costs

 

 

(9.2

)

 

 

 

 

 

 

Proceeds from exercise of stock options

 

 

13.1

 

 

 

1.8

 

 

 

 

Repurchase of common stock

 

 

 

 

 

 

 

 

(0.3

)

Cash provided (used in) by financing activities

 

 

1,430.3

 

 

 

1.8

 

 

 

(0.3

)

Effect of exchange rate changes on cash

 

 

 

 

 

 

 

 

 

Increase (decrease) in cash, cash equivalents and restricted cash

 

 

15.2

 

 

 

1.8

 

 

 

(3.6

)

Cash, cash equivalents and restricted cash at beginning of year

 

 

1.8

 

 

 

 

 

 

3.6

 

Cash, cash equivalents and restricted cash at end of year

 

$

17.0

 

 

$

1.8

 

 

$